New guidelines for MTX use in pediatric inflammatory skin disease unveiledJuly 5, 2023PediatricsLupus & Connective Tissue Diseases
Does colchicine have a role in treating excess ASCVD risk in patients with chronic inflammatory conditions?June 30, 2023GoutRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisLupus & Connective Tissue DiseasesAnkylosing spondylitis
New EULAR lupus recommendations advise using biologics, tapering steroidsJune 14, 2023Lupus & Connective Tissue Diseases
Patient selection key to lowering placebo response rates in lupus clinical trialsJune 13, 2023Lupus & Connective Tissue Diseases
Strategies for complete B-cell depletion evolve for patients with lupus nephritisJune 13, 2023Lupus & Connective Tissue Diseases
Dazodalibep may mitigate Sjögren’s syndrome, but more data are neededJune 12, 2023Lupus & Connective Tissue Diseases
EULAR systemic sclerosis recommendations now include immunosuppressantsJune 5, 2023Lupus & Connective Tissue Diseases
Encouraging telitacicept results reported in phase 3 for lupus, phase 2 for Sjögren’sJune 2, 2023Lupus & Connective Tissue Diseases
Lupus nephritis: Hopes, questions arise for baricitinibJune 1, 2023Lupus & Connective Tissue Diseases
First prospective study finds pregnancies with Sjögren’s to be largely safeMay 26, 2023Lupus & Connective Tissue Diseases
Investigational lupus drug cenerimod moves to phase 3 studies after equivocal phase 2 resultsMay 26, 2023Lupus & Connective Tissue Diseases
Severe hydroxychloroquine nonadherence linked to worse SLE outcomesMay 25, 2023Lupus & Connective Tissue Diseases
Lupus landmark study aims for personalized medicine goalsMay 24, 2023Lupus & Connective Tissue Diseases
Early remission in lupus nephritis can still progress to advanced CKDMay 23, 2023Lupus & Connective Tissue Diseases
Biomarkers for measuring lupus nephritis treatment response gain groundMay 19, 2023Lupus & Connective Tissue Diseases
